G Medical Innovations Holdings Ltd · OTC:GMVDF
G Medical Innovations — IPO Roadshow (October 2020)
26 slides from G Medical Innovations's IPO roadshow presentation, Oct 22, 2020
Slide 1: G Medical Innovations Holdings Limited Nasdaq IPO Company Presentation
At the forefront of telehealth and remote patient monitoring © 2020 All rights reserved - Past performance is not indicative of future results. Investments may be speculative, illiquid and there is a risk of principal loss. There is no guarantee that any specific outcome will be achieved. NASDAQ IPO
Slide 2: Free Writing Prospectus and Forward-Looking Statements
Filed pursuant to Rule 433 of the Securities Act of 1933, as amended. This free writing prospectus related to the proposed initial public offering of ordinary shares of G Medical Innovations Holdings Limited (“GMV” or the “company””), which are being registered on a registration statement on Form F
Slide 3: IPO Summary
Issuer 3 G Medical Innovations Holdings Limited, a Cayman Islands company Exchange & Ticker Nasdaq Global Market: GMVD Ordinary Shares outstanding prior to the completion of the IPO 54,771,648 Ordinary Shares Ordinary Shares offered 5,000,000 Ordinary Shares (1) Ordinary Shares Outstanding Immediate
Slide 4: Mission Statement
MISSION STATEMENT G Medical is a medical device, telehealth and medical services company that provides clinical grade solutions for consumers, medical professionals and healthcare institutions. Management has an established track record – Board and management have achieved US FDA approval for 48 med
Slide 5: Company Overview
COMPANY OVERVIEW Product suite includes proprietary medical devices, telehealth software solutions and patient service operations: 5 © 2020 All rights reserved - Past performance is not indicative of future results. Investments may be speculative, illiquid and there is a risk of principal loss. Ther
Slide 6: Chairman and Management Team
Dr. Kenneth R. Melani Chairman Dr. Melani has over 30 years’ experience in the healthcare industry as a provider, supplier and insurer. He has served in various critical business roles including CEO, Chief Medical Officer, and Strategy and Business Development. He founded Velocity Fund Partners LP,
Slide 7: Operating in Large Addressable Markets
G Medical has the potential to capitalize on the growing telehealth market in the USA, Asia Pacific and Europe OPERATING IN LARGE ADDRESSABLE MARKETS Mobile health sets out to reduce: (in billion USD) (in million USD) (in billion USD) CAGR: 32.3% GLOBAL CAGR: 11.3% 23 41 30 54 2 0 1 7 2 0 1 8 2 0 1
Slide 8: Products and Solutions Overview
G Medical’s multifunction devices and platforms provide end - to - end telehealth services for consumers and healthcare providers PRODUCTS AND SOLUTIONS OVERVIEW • Built - in sensors measure electrocardiogram (ECG), heart rate, oxygen saturation (SpO2), body temperature and stress • Manual data entr
Slide 9: Worldwide Regulatory Approvals
WORLDWIDE REGULATORY APPROVALS USA: FDA OTC and class 2 (510k) – includes all countries that accept FDA standards Europe: CE mark achieved – includes all countries accepting CE standards Australia & NZ: Therapeutic Goods Administration (TGA) granted Taiwan: FDA – permit licence issued China: Nationa
Slide 10: Complete Institutional & Remote Patient Solutions
COMPLETE INSTITUTIONAL & REMOTE PATIENT SOLUTIONS Prizma Sensors Prizma Medical App Users Portal Doctor Portal E M R I D TF Complete solution TELEHEALTH CONSULTATIONS Remote Vital Signs Monitoring Prizma device Consumers & Lifestyle Chronic Illness Patients Aged - Care Facilities Out - Patients COVI
Slide 11: Prizma Device – A Doctor in Your Pocket
PRIZMA DEVICE – A DOCTOR IN YOUR POCKET 1 lead ECG with arrhytmia detection algorithm Heart rate Body temperature PRIZMA connects to IOS and Android devices Smart Phones IPads and Tablets Set - Top Boxes Smart TVs Blood pressure (external) Blood glucose (external) Weight ( e x t e r n a l ) User por
Slide 12: Prizma Telehealth App and Web-Based Portals
PRIZMA TELEHEALTH APP AND WEB - BASED PORTALS PATIENT PORTAL PHYSICIAN PORTAL Top menu: help and 3rd party systems like CRM, Call Center and Online Store Patients medical history with option to edit and view for comprehensive status Abnormal measurements indication based on flexible time filter Inco
Slide 13: Extended Holter Patch System and Reports
Continuously (beat to beat) records a multi - channel (up to 6 leads) ECG and saves the waveforms to SD card to compile an extended ambulatory report which is provided directly to the physician. EXTENDED HOLTER PATCH SYSTEM AND REPORTS Lead I, lead II, lead III, aVL, aVF, and aVR Mobile Cardiac Tele
Slide 14: G Medical Patch Allows for Enhanced Patient Care
G Medical’s Patch provides real time vital signs monitoring, allowing for easier decision making and enhanced patient care while reducing healthcare costs G MEDICAL PATCH ALLOWS FOR ENHANCED PATIENT CARE 1 GMP monitors patient and transmits via 4G/ WiFi to the G Medical Innovations Cloud 3 Clinicall
Slide 15: Remote Patient Monitoring Services
Independent Diagnostic Testing Facilities (IDTF): • Undertaken through 100% owned monitoring centers in the USA • Allows patients and physicians to track, monitor and share medical data and patient history • Subscription - as - a - service model generates recurring revenue • Operations are Medicare
Slide 16: Business Model: Overview
Prizma Smartphone App eHealth subscriptions Device sales Support fees Health Providers Insurers Chronic care management Concierge medicine Analytics Platforms Diagnostics Vital signs trending Store and share Patient alerts and reminders IDTF & VSMS Vital Signs Vital signs system fee Device sales Lic
Slide 17: Providing Solutions to a Large Market Ecosystem
Our next generation mobile technologies provide complete linkage allowing for better business practices and enhanced patient care. Solution suite is applicable to individuals and healthcare providers, outlining a large market opportunity: PROVIDING SOLUTIONS TO A LARGE MARKET ECOSYSTEM 2B BUSINESS 2
Slide 18: Medicare Reimbursement for Remote Patient Monitoring
9 9 4 53 Remote monitoring of physiologic parameter(s) initial; set - up and patient education on use of equipment. Average one - time Medicare payment of US$21 9 9 4 5 4 Remote monitoring of of physiologic parameter(s)initial; device(s) supply with daily recording(s) or programmed alert(s) transmis
Slide 19: Key Growth Focus: USA
Recent progress in the USA has laid a strong foundation for growth KEY GROWTH FOCUS: USA • Allows for Prizma to be sold OTC without a prescription • Authorization granted on the US FDA’s policy for COVID - 19 public health emergency • Multiple sales avenues being explored including direct to consume
Slide 20: Other Recent Transformational Initiatives
OTHER RECENT TRANSFORMATIONAL INITIATIVES 20 © 2020 All rights reserved - Past performance is not indicative of future results. Investments may be speculative, illiquid and there is a risk of principal loss. There is no guarantee that any specific outcome will be achieved. G Medical is now its deplo
Slide 21: Agreement with Guthy-Renker to Drive US Growth
Since 1988, Guthy - Renker has discovered and developed and sold billions of dollars of high quality consumer products in the beauty, skincare, and wellness categories. GRS will act as GMed’s exclusive creative and media agency in the U . S . for all TV production, radio creative and social media, i
Slide 22: Recent Progress by Region
USA: • Prizma granted OTC approval by FDA – device can now be bought by consumers without a prescription • GMP/VSMS (Patch) granted FDA (EUA) approval for COVID - 19 patient treatment • Distribution agreement with LiveCare to integrate Prizma into Life+ patient monitoring platform • Deployment of ID
Slide 23: Financial Highlights
Narrowing down of net losses: Net loss narrowed due to increased revenue and decreased OPEX. Revenue is expected to continue to increase with US hospital deployments and potential China regulatory approvals Enhanced generation of operating cash flow: Net operating cash flow has improved partially du
Slide 24: Nasdaq & NYSE Listed Peers
NASDAQ & NYSE LISTED PEERS Company name C od e Description E n t e r p r i s e Value* LTM Revenue (as of 6/30/2020)* EV/ LTM Revenue multiple* Biotelemetry Inc NASDAQ: BEAT Ambulatory outpatient management solutions for monitoring clinical information. Focused on diagnosis and monitoring of cardiac
Slide 25: Extensive Global Network
U S A : • Remote patient monitoring • Device sales and distribution partners • Hospital and Institutional partners China: • Manufacturing through regulatory - approved production facility • Device regulatory approvals pending Israel: • R&D and regulatory Established in 2014, G Medical has built a gl
Slide 26: Thank you
26 Thank you © 2020 All rights reserved - Past performance is not indicative of future results. Investments may be speculative, illiquid and there is a risk of principal loss. There is no guarantee that any specific outcome will be achieved.
G Medical Innovations Holdings — IPO Roadshow (October 2020) on 6ix